Opthea Receives A$8.8 million R&D Tax Incentive
MELBOURNE, Australia, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies ...
Read moreMELBOURNE, Australia, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies ...
Read moreHyundai Motor Group Innovation Center Singapore (HMGICS) opens to progress onwards, redefining future mobility production and customer experienceCell-based production and ...
Read moreHyundai Motor Group Innovation Center Singapore (HMGICS) opens to progress onwards, redefining future mobility production and customer experienceCell-based production and ...
Read moreSmart Immune to host R&D KOL webinar on thymus-empowered ProTcell platform Clinical-stage T-cell progenitor therapy aims to re-arm the immune ...
Read morePress Release Nokia Bell Labs and Aramco announce R&D collaboration to support priority industries Collaboration is expected to develop advanced ...
Read moreTokyo, Japan and Cambridge, UK, 7 November 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) announces ...
Read moreCompany builds on deep structure-based drug design capabilities to add protein therapeutics to pipeline:BCX17725 for Netherton syndrome — entering clinic ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.